US Patent Number
A method of treating leukemia which includes administering an effective amount of composition comprising suramin and a biological response modifier, wherein the suramin and the biological response modifier show synergistic or additive anti-leukemic activity. A pharmaceutical composition is also disclosed.
University of Kentucky Research Foundation, Lexington, Ky.
Doukas, Michael A., "Combination Anti-Leukimic Therapy by Utilizing Suramin and Biologic Response Modifiers" (2000). Internal Medicine Faculty Patents. 5.